Next Article in Journal
Importance of Beta Cell Function for the Treatment of Type 2 Diabetes
Next Article in Special Issue
Counseling Challenges with Variants of Uncertain Significance and Incidental Findings in Prenatal Genetic Screening and Diagnosis
Previous Article in Journal
Consequences of Abdominal Adiposity within the Metabolic Syndrome Paradigm in Black People of African Ancestry
Previous Article in Special Issue
Screening and Invasive Testing in Twins
Open AccessArticle

Non-Invasive Prenatal Diagnosis in the Management of Preimplantation Genetic Diagnosis Pregnancies

1
Genetics Service, Fundacion Jimenez Diaz-IIS, Avda. Reyes Catolicos, 2, 28040 Madrid, Spain
2
Assisted Reproduction Unit, Fundacion Jimenez Diaz-IIS, Avda. Reyes Catolicos, 2, 28040 Madrid, Spain
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Clin. Med. 2014, 3(3), 913-922; https://doi.org/10.3390/jcm3030913
Received: 2 April 2014 / Revised: 27 May 2014 / Accepted: 25 June 2014 / Published: 14 August 2014
(This article belongs to the Special Issue Prenatal Genetic Screening and Diagnosis-Part 2)
Prenatal diagnosis (PD) is recommended in pregnancies after a Preimplantation Genetic Diagnosis (PGD). However, conventional PD entails a risk of fetal loss which makes PGD patients reluctant to undergo obstetric invasive procedures. The presence of circulating fetal DNA in maternal blood allows performing a non-invasive prenatal diagnosis (NIPD) without risk for the pregnancy outcome. This work shows the introduction of NIPD for confirmation of PGD results in eight pregnancies. In those pregnancies referred to PGD for an X-linked disorder (six out of eight), fetal sex determination in maternal blood was performed to confirm fetal sex. One pregnancy referred to PGD for Marfan syndrome and one referred for Huntington disease (HD) were also analyzed. In seven out of eight cases, PGD results were confirmed by NIPD in maternal blood. No results were obtained in the HD pregnancy. NIPD in PGD pregnancies can be a reliable alternative for couples that after a long process feel reluctant to undergo PD due to the risk of pregnancy loss. View Full-Text
Keywords: ccffDNA; maternal plasma; NIPD; preimplantation genetic diagnosis ccffDNA; maternal plasma; NIPD; preimplantation genetic diagnosis
Show Figures

Figure 1

MDPI and ACS Style

Bustamante-Aragones, A.; Perlado-Marina, S.; Trujillo-Tiebas, M.J.; Gallego-Merlo, J.; Lorda-Sanchez, I.; Rodríguez-Ramirez, L.; Linares, C.; Hernandez, C.; De Alba, M.R. Non-Invasive Prenatal Diagnosis in the Management of Preimplantation Genetic Diagnosis Pregnancies. J. Clin. Med. 2014, 3, 913-922.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop